82 related articles for article (PubMed ID: 20854790)
1. Requirement of SIRPα for protective immunity against Leishmania major.
Morimoto N; Murata Y; Motegi S; Suzue K; Saito Y; Okazawa H; Ohnishi H; Kotani T; Kusakari S; Ishikawa O; Matozaki T
Biochem Biophys Res Commun; 2010 Oct; 401(3):385-9. PubMed ID: 20854790
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
3. Leishmania major: differential resistance to infection in C57BL/6 (high interferon-alpha/beta) and congenic B6.C-H-28c (low interferon-alpha/beta) mice.
Shankar AH; Morin P; Titus RG
Exp Parasitol; 1996 Nov; 84(2):136-43. PubMed ID: 8932763
[TBL] [Abstract][Full Text] [Related]
4. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
5. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
6. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
7. Essential roles of SIRPα in homeostatic regulation of skin dendritic cells.
Iwamura H; Saito Y; Sato-Hashimoto M; Ohnishi H; Murata Y; Okazawa H; Kanazawa Y; Kaneko T; Kusakari S; Kotani T; Nojima Y; Matozaki T
Immunol Lett; 2011 Mar; 135(1-2):100-7. PubMed ID: 20955735
[TBL] [Abstract][Full Text] [Related]
8. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
9. Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway.
Rosas LE; Keiser T; Pyles R; Durbin J; Satoskar AR
Eur J Immunol; 2003 Jul; 33(7):1799-805. PubMed ID: 12811839
[TBL] [Abstract][Full Text] [Related]
10. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
12. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
13. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
14. Mice defective in Fas are highly susceptible to Leishmania major infection despite elevated IL-12 synthesis, strong Th1 responses, and enhanced nitric oxide production.
Huang FP; Xu D; Esfandiari EO; Sands W; Wei XQ; Liew FY
J Immunol; 1998 May; 160(9):4143-7. PubMed ID: 9574511
[TBL] [Abstract][Full Text] [Related]
15. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
16. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
[TBL] [Abstract][Full Text] [Related]
17. Role of SIRPα in regulation of mucosal immunity in the intestine.
Kanazawa Y; Saito Y; Supriatna Y; Tezuka H; Kotani T; Murata Y; Okazawa H; Ohnishi H; Kinouchi Y; Nojima Y; Ohteki T; Shimosegawa T; Matozaki T
Genes Cells; 2010 Dec; 15(12):1189-200. PubMed ID: 21040253
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
Fritzsche C; Schleicher U; Bogdan C
Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
[TBL] [Abstract][Full Text] [Related]
20. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
